Physician profile
Chaim Putterman
NPI 1992894281
$24,660.69
in general payments reported to CMS, 2019-2025
12 companies · $975 in 2025
The $975 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,849 · 2020: $3,151 · 2021: $1,163 · 2022: $3,450 · 2023: $11K · 2024: $981 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $1,720 · Food and Beverage: $72.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,255.83 |
| Travel and Lodging | $1,719.89 |
| Food and Beverage | $72.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11,139.79 | 2019-2023 | |
| Janssen Biotech, INC. | $3,788.11 | 2019 | |
| Ucb Sa | $3,450.00 | 2022 | |
| Boehringer Ingelheim International Gmbh | $3,150.67 | 2020 | |
| Biogen, INC. | $1,162.50 | 2021 | |
| Glaxosmithkline, LLC. | $975.00 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $508.33 | 2024 | |
| Beigene USA, INC. | $472.50 | 2024 | |
| Amgen INC. | $13.79 | 2019 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chaim Putterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.